GlobeNewswire: BioRestorative Therapies Contains the last 10 of 9 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T16:13:20ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2015/12/02/792277/10157702/en/BioRestorative-Therapies-Appoints-John-M-Desmarais-J-D-to-Its-Board-of-Directors.html?f=22&fvtc=4&fvtv=26073BioRestorative Therapies Appoints John M. Desmarais, J.D. to Its Board of Directors2015-12-02T13:00:00Z<![CDATA[MELVILLE, N.Y., Dec. 2, 2015 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB:BRTX), a life sciences company focused on stem cell-based therapies, today announced the appointment of John M. Desmarais, J.D. to its Board of Directors.]]>https://www.globenewswire.com/news-release/2015/11/19/788759/10156789/en/BioRestorative-Therapies-Granted-Key-Metabolic-Patent.html?f=22&fvtc=4&fvtv=26073BioRestorative Therapies Granted Key Metabolic Patent2015-11-19T13:00:00Z<![CDATA[Potential Therapeutics Include Diabetes, Hypertension, Cardiac Deficiency and Obesity MELVILLE, N.Y., Nov. 19, 2015 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCQB:BRTX), a life sciences company focused on stem cell-based therapies, today announced the United States Patent and Trademark Office has issued a US patent covering methods related to BRT's metabolic program (ThermoStem® Program).]]>https://www.globenewswire.com/news-release/2015/11/03/782915/10154823/en/BioRestorative-Therapies-Announces-Patent-Granted-for-Its-Licensed-Curved-Needle-Device.html?f=22&fvtc=4&fvtv=26073BioRestorative Therapies Announces Patent Granted for Its Licensed Curved Needle Device2015-11-03T13:30:00Z<![CDATA[MELVILLE, N.Y., Nov. 3, 2015 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCQB:BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Company is the beneficiary of a patent granted for a licensed curved needle device ("CND") designed to deliver cells and/or other therapeutic products or material to a site having damage in need of facilitated repair.]]>https://www.globenewswire.com/news-release/2015/09/15/768322/10149243/en/BioRestorative-Therapies-Announces-Research-Collaboration-With-University-of-Pennsylvania.html?f=22&fvtc=4&fvtv=26073BioRestorative Therapies Announces Research Collaboration With University of Pennsylvania2015-09-15T12:00:00Z<![CDATA[Study to Advance Understanding of Brown Adipose (Fat) Biology and Its Role in Metabolic Disorders MELVILLE, N.Y., Sept. 15, 2015 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCQB:BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Company has entered into a one-year research collaboration agreement with the University of Pennsylvania. The research is intended to develop the Company's ThermoStem® Program by advancing the understanding of brown adipose ("brown fat") biology and its role in metabolic disorders. Brown fat is recognized as playing a role in caloric burning, as well as potentially regulating glucose and lipid levels.]]>https://www.globenewswire.com/news-release/2015/07/20/753428/10142257/en/BioRestorative-Therapies-to-Evaluate-Cell-Delivery-Technology-to-Advance-Metabolic-Program-Towards-Human-Trials.html?f=22&fvtc=4&fvtv=26073BioRestorative Therapies to Evaluate Cell Delivery Technology to Advance Metabolic Program Towards Human Trials2015-07-20T12:30:00Z<![CDATA[Potential Delivery System for Treatment of Metabolic Disorders Using Brown Adipose (Fat) Derived Stem Cells MELVILLE, N.Y., July 20, 2015 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or "the Company") (OTCQB:BRTX), a life sciences company focused on stem cell-based therapies, today announced that the Company has begun to evaluate encapsulation technology for potential use as a cell delivery system for the Company's metabolic program.]]>https://www.globenewswire.com/news-release/2015/07/06/750050/10140744/en/BioRestorative-Therapies-Inc-Announces-Reverse-Stock-Split-in-Preparation-for-Planned-Uplisting-to-NASDAQ-Capital-Market.html?f=22&fvtc=4&fvtv=26073BioRestorative Therapies, Inc. Announces Reverse Stock Split in Preparation for Planned Uplisting to NASDAQ Capital Market2015-07-06T21:00:00Z<![CDATA[MELVILLE, N.Y., July 6, 2015 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRTX" or the "Company") (OTCQB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced a 1-for-20 reverse split of its common stock in preparation for the planned listing of its common stock on the NASDAQ Capital Market. The reverse stock split will become effective on Tuesday, July 7, 2015 and the Company's common stock will begin trading on a split-adjusted basis under the temporary ticker symbol "BRTXD." This temporary ticker symbol will remain in effect for 20 days, at which point it will revert back to "BRTX." The new CUSIP number is 090655408.]]>https://www.globenewswire.com/news-release/2015/06/02/741342/10136875/en/BioRestorative-Therapies-Announces-Conversion-of-5-15-Million-of-Debt-to-Equity.html?f=22&fvtc=4&fvtv=26073BioRestorative Therapies Announces Conversion of $5.15 Million of Debt to Equity2015-06-02T12:30:00Z<![CDATA[MELVILLE, N.Y., June 2, 2015 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT or "the Company") (OTCQB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced the conversion of $5.15 million of debt into common shares and warrants.]]>https://www.globenewswire.com/news-release/2015/05/27/739481/10136009/en/BioRestorative-Therapies-to-Present-ThermoStem-R-Data-at-21st-Annual-Meeting-of-the-International-Society-for-Cellular-Therapy.html?f=22&fvtc=4&fvtv=26073BioRestorative Therapies to Present ThermoStem(R) Data at 21st Annual Meeting of the International Society for Cellular Therapy2015-05-27T12:30:00Z<![CDATA[Presentations to Cover Development of a 3D Brown Adipose Tissue Construct MELVILLE, N.Y., May 27, 2015 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT" or "the Company") (OTCQB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that Francisco Silva, Vice President of Research and Development and Chief Scientist, will present data from the Company's ongoing programs to develop a human-derived 3D brown adipose tissue construct at the 21]]>https://www.globenewswire.com/news-release/2015/05/26/739013/10135730/en/BioRestorative-Therapies-to-Present-at-the-2015-Marcum-MicroCap-Conference-in-New-York-City.html?f=22&fvtc=4&fvtv=26073BioRestorative Therapies to Present at the 2015 Marcum MicroCap Conference in New York City2015-05-26T12:30:00Z<![CDATA[MELVILLE, N.Y., May 26, 2015 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BRT or "the Company") (OTCQB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that Mark Weinreb, the company's CEO, will present a company overview at the 2015 Marcum MicroCap Conference on Thursday, May 28]]>